Deregulated E2F transcriptional activity in autonomously growing melanoma cells

Journal of Experimental Medicine

Volumn 191, Issue 6, 2000, Pages 1005-1015

  Halaban, Ruth ^a   Cheng, Elaine ^a   Smicun, Yoel ^a   Germino, Joseph ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

Cyclins; Melanocytes; p107; p130; pRb

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLINE; GENE PRODUCT; GROWTH FACTOR; INHIBITOR PROTEIN; TRANSCRIPTION FACTOR E2F;

ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM;

CARRIER PROTEINS; CELL AGING; CELL CYCLE PROTEINS; CELL DIVISION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYCLIN-DEPENDENT KINASES; CYCLINS; DNA-BINDING PROTEINS; DOWN-REGULATION; DROSOPHILA PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; E2F2 TRANSCRIPTION FACTOR; E2F3 TRANSCRIPTION FACTOR; E2F4 TRANSCRIPTION FACTOR; E2F5 TRANSCRIPTION FACTOR; E2F6 TRANSCRIPTION FACTOR; ENZYME INHIBITORS; FLAVONOIDS; HUMANS; MELANOCYTES; MELANOMA; PHOSPHORYLATION; PIPERIDINES; PROTEIN BINDING; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0034689006     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.6.1005     Document Type: Article

References (64)

1. Melanoma cell autonomous growth: The Rb/E2F pathway
2. Growth factors and melanomas
3. Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes
4. Growth factor independence and growth regulatory pathways in human melanoma development
5. The pl6-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis
6. Melanomas, from the cell cycle point of view
7. G1 events and regulation of cell proliferation
8. The retinoblastoma protein pathway and the restriction point
9. The restriction point and control of cell proliferation
10. Toward an understanding of the functional complexity of the E2F and retinoblastoma families
11. Transcriptional control by E2F
12. The cellular effects of E2F overexpression
13. Growth factor-regulated G1 cyclins
14. G1 phase progression: Cycling on cue
15. D-type cyclins
16. Mammalian G1 cyclins and cell cycle progression
17. Cell-cycle control and its watchman
18. Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth
19. Role of E2F in cell cycle control and cancer
20. Regulation of the CDK inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F
21. E2F-6, a member of the E2F family that can behave as a transcriptional repressor
22. E2F-6: A novel member of the E2F family is an inhibitor of E2F-dependent transcription
23. Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6
24. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis
25. Induction of DNA synthesis and apoptosis are separable functions of E2F-1
26. E2F-l-induced p53-independent apoptosis in transgenic mice
27. Distinct roles for E2F proteins in cell growth control and apoptosis
28. The molecular basis of E2F-l/DP-l-induced S-phase entry and apoptosis
29. Human melanocytes cultured from nevi and melanomas
30. Growth regulation in normal and malignant melanocytes
31. Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1(E132), but not by deletion of pl6(INK4A) or p21WAF1/CIP1
32. KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells
33. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells
34. Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells
35. Flavopiridol mediates Cell cycle arrest and apoptosis in esophageal cancer cells
36. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells
37. Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis
38. Regulation of FGF-2 expression in melanoma cells by the c-Myb proto-oncoprotein
39. Functional analysis of E2F transcription factor
40. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
41. D-type cyclin-dependent kinase activity in mammalian cells
42. Distinct mechanisms control the accumulation of the Rb-related p107 and p130 proteins during cell growth
43. Differential regulation of the retinoblastoma family of proteins during cell proliferation and differentiation
44. The retinoblastoma protein and cell cycle control
45. Functional analysis of pRb2/pl30 interaction with cyclins
46. Cell cycle-specific association of E2F with the p130 ElA-binding protein
47. Cell cycle gene expression and E2F transcription factor complexes in human melanoma cells induced to terminally differentiate
48. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner
49. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes
50. Terminal differentiation and senescence in the human melanocyte: Repression of tyrosine-phosphorylation of the extracellular signal-regulated kinase 2 selectively defines the two phenotypes
51. Aging in epidermal melanocytes: Cell cycle genes and melanins
52. Retinoblastoma protein associates with SP1 and activates the hamster dihydrofolate reductase promoter
53. The microphthalmia gene product interacts with the retinoblastoma protein in vitro and is a target for deregulation of melanocyte-specific transcription
54. pRB and pl07/p130 are required for the regulated expression of different sets of E2F responsive genes
55. Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53
56. Control of retinoblastoma protein-independent hematopoietic cell cycle by the pRB-related p130
57. Human melanoma genetics
58. Cyclin-dependent kinase inhibitors and human cancer
59. Cyclin Dl oncoprotein aberrantly accumulates in malignancies of diverse histogenesis
60. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer
61. Cyclin E-induced S phase without activation of the pRb/E2F pathway
62. Cyclin E, a redundant cyclin in breast cancer
63. Fibroblast growth factors in normal and malignant melanocytes
64. DNA amplification at l1q13 in human cancer: From complexity to perplexity